Insider Trading June 29, 2026 03:16 PM

TTM Technologies COO James P. Walsh Executes $441,481 Stock Sale Under Pre-Arranged Plan

Executive divestment coincides with significant corporate expansion moves and index reclassification for the defense and aerospace electronics manufacturer.

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
TTMI

James P. Walsh, Chief Operating Officer of TTM Technologies Inc. (NASDAQ: TTMI), executed a sale of 2,113 shares of common stock on June 25, 2026, generating total proceeds of $441,481. The transaction, conducted under a 10b5-1 trading plan established on February 24, 2026, was solely intended to cover tax liabilities arising from the vesting of restricted stock units (RSUs). The sale occurred at prices ranging from $204.95 to $218.27 per share. Following this divestment, Mr. Walsh retains direct ownership of 33,783 shares of TTM Technologies common stock.

TTM Technologies COO James P. Walsh Executes $441,481 Stock Sale Under Pre-Arranged Plan
TTMI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Executive Trading Activity: The sale by COO James P. Walsh represents a routine liquidity event under a pre-arranged 10b5-1 plan, specifically tied to tax obligations from RSU vesting, rather than a reflection of operational sentiment.
  • Strategic Expansion in Europe: TTM Technologies has announced the intent to acquire Swiss Technology Group AG and ILFA GmbH in separate all-cash transactions, subject to regulatory approval. This strategic initiative aims to expand the company's footprint in the European market, particularly within the medical and aerospace sectors.
  • Defense Infrastructure Investment: The company has opened a new $130 million defense electronics facility in Syracuse, New York. This 215,000-square-foot facility, partially funded by the U.S. Department of Defense, is dedicated to producing advanced circuit boards for aerospace and defense applications.

James P. Walsh, serving as the Chief Operating Officer of TTM Technologies Inc. (NASDAQ: TTMI), executed a significant divestment of company equity on June 25, 2026. The transaction involved the sale of 2,113 shares of common stock, resulting in total proceeds of $441,481. This financial activity occurred while the company's shares were trading at $184.47, a figure that marks a substantial 13.5% decline from the previous close of $210.57 over the preceding week, according to data from InvestingPro.

The execution of these sales took place across multiple transactions, with share prices ranging between $204.95 and $218.27. Crucially, these dispositions were conducted pursuant to a 10b5-1 trading plan that was formally adopted on February 24, 2026. The specific purpose of this transaction was to cover tax liabilities associated with the vesting of restricted stock units (RSUs). Following the completion of these transactions, Mr. Walsh continues to hold a direct position of 33,783 shares of TTM Technologies common stock.

While the stock has experienced a recent pullback, broader performance metrics indicate a remarkable 376% return over the past year. However, analysis from InvestingPro suggests that the company appears overvalued at its current price levels based on fair value assessments. Investors seeking detailed insights into TTMI's valuation and performance metrics may access comprehensive research reports available through InvestingPro for this and over 1,400 other US equities.

  • Executive Trading Activity: The sale by COO James P. Walsh represents a routine liquidity event under a pre-arranged 10b5-1 plan, specifically tied to tax obligations from RSU vesting, rather than a reflection of operational sentiment.
  • Strategic Expansion in Europe: TTM Technologies has announced the intent to acquire Swiss Technology Group AG and ILFA GmbH in separate all-cash transactions, subject to regulatory approval. This strategic initiative aims to expand the company's footprint in the European market, particularly within the medical and aerospace sectors.
  • Defense Infrastructure Investment: The company has opened a new $130 million defense electronics facility in Syracuse, New York. This 215,000-square-foot facility, partially funded by the U.S. Department of Defense, is dedicated to producing advanced circuit boards for aerospace and defense applications.

Further operational developments include TTM Technologies' transition from the Russell 2000 Index to the Russell 1000 Index, effective after the market close on June 26, 2026. This reclassification reflects the company's growth trajectory and positions it among the largest publicly traded companies in the United States. Additionally, TTM's Mini-Xinger product portfolio has received AEC-Q200 qualification accreditation. This accreditation confirms the suitability of these products for automotive and high-reliability applications, ensuring they meet rigorous standards for stress testing and reliability.

These developments collectively highlight TTM Technologies' ongoing efforts to expand its market presence and enhance its product offerings. The company's stock data reflects real-time trading activity, with the latest recorded price at $184.73, representing a decline of $6.77 or 3.53% as of 15:26:58 USD. Investors can utilize fair value calculators incorporating 17 proven industry valuation models to assess whether TTMI represents a bargain at current levels.

Risks

  • Valuation Concerns: InvestingPro analysis suggests the company appears overvalued at current levels based on fair value assessments, indicating potential downside risk for investors entering at present price points.
  • Regulatory Dependencies: The acquisition of Swiss Technology Group AG and ILFA GmbH is contingent upon regulatory approvals, introducing uncertainty regarding the timeline and successful completion of these strategic expansions.
  • Market Volatility: The stock has experienced a sharp 13.5% decline over the past week, reflecting short-term market volatility that could impact investor sentiment and liquidity.

More from Insider Trading

Oscar Health CEO Mark Bertolini Executes $34.9 Million Stock Sale Jun 29, 2026 Workday Founder David A. Duffield Executes $12.4 Million Share Sale Under Pre-Arranged Plan Jun 29, 2026 Phio Pharmaceuticals CEO Robert Bitterman Acquires $9,900 in Company Shares Jun 29, 2026 Mission Produce CFO Executes $60,650 Stock Sale Amid Mixed Financial Signals Jun 29, 2026 TTM Technologies CFO Executes Pre-Arranged Share Sale Amid Strategic Expansion Jun 29, 2026